To assess the impact of the C2 TOP2A+ TCs subgroup on the progression of ovarian cancer and patient outcomes, we developed a novel predictive model, the TOP2A TCs Risk Score (TTRS), through multivariate Cox analysis. The gene discussed is TOP2A; the disease is ovarian carcinoma.